The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis
Abstract
This literature review and the recommendations herein were prepared for the American Gastroenterological Association Clinical Practice Committee. The paper was approved by the Committee on May 16, 2004, and by the AGA Governing Board on September 23, 2004.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DGP is estimated to affect 5% − 12% of individuals with long-term diabetes, in cohorts with systematic gastric emptying evaluation (symptom-based criteria plus objective testing) [7, 8]”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [7]
Citations
Cites
Bytzer, P., Talley, N. J., Leemon, M., Young, L. J., Jones, M. P., & Horowitz, M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.16.1989 · Cited by 632
Soykan, I., Sivri, B., Sarosiek, I., Kiernan, B., & Mccallum, R. W. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026665728213 · Cited by 575
Prather, C. M., Camilleri, M., Zinsmeister, A. R., McKinzie, S., & Thomforde, G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70251-4 · Cited by 410
Watkins, C. C., Sawa, A., Jaffrey, S., Blackshaw, S., Barrow, R. K., Snyder, S. H., & Ferris, C. D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8273 · Cited by 268
Cyclic vomiting syndrome in adults
Abell, T. L., Adams, K. A., Boles, R. G., Bousvaros, A., Chong, S. K. F., Fleisher, D. R., Hasler, W. L., Hyman, P. E., Issenman, R. M., Li, B. U. K., et al. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01113.x · Cited by 194
Self-citationMetoclopramide therapy in patients with delayed gastric emptying: A randomized, double-blind study
Perkel, M. S., Moore, C., Hersh, T., & Davidson, E. D. (1979) · Digestive Diseases and Sciences · doi:10.1007/bf01314461 · Cited by 158
Vassallo, M., Camilleri, M., Caron, B. L., & Low, P. A. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90609-o · Cited by 95
Flagged first, then by citations
Research works printed but not linked: 277
- Parkman, 1987, Esophagitis and other gastrointestinal disorders associated with diabetic gastroparesis, Arch Intern Med, 147, 1477, 10.1001/archinte.147.8.1477 · DOI
- Blum, 2000, A new endoscopic technique for the removal of gastric phytobezoars, Gastrointest Endosc, 52, 404, 10.1067/mge.2000.108407 · DOI
- Stanghellini, 1996, Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia, Gastroenterology, 110, 1036, 10.1053/gast.1996.v110.pm8612991 · DOI
- Sarnelli, 2003, Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia, Am J Gastroenterol, 98, 783, 10.1111/j.1572-0241.2003.07389.x · DOI
- Revicki, 2003, Development and validation of a patient-assessed gastroparesis symptoms severity measure, Aliment Pharmacol Ther, 18, 141, 10.1046/j.1365-2036.2003.01612.x · DOI
- Horowitz, 1989, Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus, Diabetologia, 32, 151, 10.1007/BF00265086 · DOI
- Koch, 1989, Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis, Am J Gastroenterol, 84, 1069
- Talley, 1989, Lack of association between gastric emptying of solids and symptoms in nonulcer dyspepsia, J Clin Gastroenterol, 11, 625, 10.1097/00004836-198912000-00005 · DOI
- Jones, 2001, Predictors of delayed gastric emptying in diabetes, Diabetes Care, 24, 1264, 10.2337/diacare.24.7.1264 · DOI
- Jian, 1989, Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia, Dig Dis Sci, 34, 657, 10.1007/BF01540334 · DOI
- Hoogerwerf, 1999, Pain, Am J Gastroenterol, 94, 1029, 10.1111/j.1572-0241.1999.01008.x · DOI
- Lemann, 1991, Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia, Dig Dis Sci, 36, 1249, 10.1007/BF01307517 · DOI
- Samsom, 1995, Compliance of the proximal stomach and dyspeptic symptoms in patients with type 1 diabetes mellitus, Dig Dis Sci, 40, 2037, 10.1007/BF02208676 · DOI
- Datz, 1987, Gender-related differences in gastric emptying, J Nucl Med, 28, 1204
- Gill, 1987, Effect of the menstrual cycle on gastric emptying, Digestion, 36, 168, 10.1159/000199414 · DOI
- Maleki, 2000, Gastrointestinal tract symptoms among persons with diabetes mellitus in the community, Arch Intern Med, 160, 2808, 10.1001/archinte.160.18.2808 · DOI · Paper page
- Enck, 1999, Quality of life in patients with upper gastrointestinal symptoms, Scand J Gastroenterol, 34, 48, 10.1080/003655299750025264 · DOI
- Farup, 1998, Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis, Diabetes Care, 21, 1699, 10.2337/diacare.21.10.1699 · DOI
- Bell, 2002, Hospitalizations and outcomes for diabetic gastroparesis in North Carolina, South Med J, 95, 1297, 10.1097/00007611-200295110-00014 · DOI
- Abell, 2001, Gastric electrical stimulation is superior to standard pharmacological treatment in reducing health care costs and hospital stays and in improving quality of life in patients with severe upper GI motor disorders (abstr), Am J Gastroenterol, 235, s258, 10.1016/S0002-9270(01)03606-1 · DOI
- Botoman, 2003, Motility and GI function studies billing and coding guidelines, Am J Gastroenterol, 98, 1228, 10.1111/j.1572-0241.2003.t01-1-07493.x · DOI
- Quigley, 2001, AGA technical review on nausea and vomiting, Gastroenterology, 120, 263, 10.1053/gast.2001.20516 · DOI
- Herlinger, 1995, Guide to imaging of the small bowel, Gastroenterol Clin North Am, 24, 309, 10.1016/S0889-8553(21)00195-3 · DOI
- Hornbuckle, 2000, The diagnosis and work-up of the patient with gastroparesis, J Clin Gastroenterol, 30, 117, 10.1097/00004836-200003000-00004 · DOI
- Parkman, 1995, Gastroduodenal motility and dysmotility, Am J Gastroenterol, 90, 869
- Malagelada, 1980, Gastric motor abnormalities in diabetic and postvagotomy gastroparesis, Gastroenterology, 78, 286, 10.1016/0016-5085(80)90578-8 · DOI
- Galil, 1993, Isotope gastric emptying tests in clinical practice, Gut, 34, 916, 10.1136/gut.34.7.916 · DOI
- Tougas, 2000, Assessment of gastric emptying using a low fat meal, Am J Gastroenterol, 95, 1456, 10.1111/j.1572-0241.2000.02076.x · DOI
- Kim, 2000, Novel testing of human gastric motor and sensory functions, Am J Gastroenterol, 95, 3365, 10.1111/j.1572-0241.2000.03346.x · DOI
- Lartigue, 1994, Inter- and intrasubject variability of solid and liquid gastric emptying parameters. A scintigraphic study in healthy subjects and diabetic patients, Dig Dis Sci, 39, 109, 10.1007/BF02090069 · DOI
- Thomforde, 1995, Evaluation of an inexpensive screening scintigraphic test of gastric emptying, J Nucl Med, 36, 93
- Guo, 2001, Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis, Dig Dis Sci, 46, 24, 10.1023/A:1005697422454 · DOI
- Camilleri, 1998, Measurement of gastroduodenal motility in the GI laboratory, Gastroenterology, 115, 747, 10.1016/S0016-5085(98)70155-6 · DOI
- Ghoos, 1993, Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test, Gastroenterology, 104, 1640, 10.1016/0016-5085(93)90640-X · DOI
- Choi, 1998, Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids, Am J Gastroenterol, 93, 92, 10.1111/j.1572-0241.1998.092_c.x · DOI
- Bromer, 2002, Simultaneous measurement of gastric emptying with a simple muffin meal using 13C-octanoate breath test and scintigraphy in normal subjects and patients with in dyspeptic symptoms, Dig Dis Sci, 47, 1657, 10.1023/A:1015856211261 · DOI
- Chen, 1993, Clinical applications of electrogastrography, Am J Gastroenterol, 88, 1324
- Parkman, 2003, Electrogastrography, Neurogastroenterol Motil, 15, 488, 10.1046/j.1365-2982.2003.00396.x · DOI
- Chen, 1996, Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis, Dig Dis Sci, 41, 1538, 10.1007/BF02087897 · DOI
- Parkman, 1997, Electrogastrography and gastric emptying scintigraphy are complementary for assessment of dyspepsia, J Clin Gastroenterol, 24, 214, 10.1097/00004836-199706000-00006 · DOI
- Jebbink, 1994, Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type 1 diabetes mellitus, Gastroenterology, 107, 1390, 10.1016/0016-5085(94)90541-X · DOI
- Fraser, 1994, Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis—effects of cisapride, Gut, 35, 172, 10.1136/gut.35.2.172 · DOI
- Mearin, 1986, Pyloric dysfunction in diabetics with recurrent nausea and vomiting, Gastroenterology, 90, 1919, 10.1016/0016-5085(86)90262-3 · DOI · Paper page
- Dooley, 1988, Abnormalities of the migrating motor complex in diabetics with autonomic neuropathy and diarrhea, Scand J Gastroenterol, 23, 217, 10.3109/00365528809103971 · DOI
- Camilleri, 1984, Abnormal intestinal motility in diabetics with the gastroparesis syndrome, Eur J Clin Invest, 14, 420, 10.1111/j.1365-2362.1984.tb01206.x · DOI
- Camilleri, 1986, Relationship between impaired gastric emptying and abnormal gastrointestinal motility, Gastroenterology, 91, 94, 10.1016/0016-5085(86)90444-0 · DOI
- Camilleri, 1993, Study of human gastroduodenojejunal motility—applied physiology in clinical practice, Dig Dis Sci, 38, 785, 10.1007/BF01295902 · DOI
- Frank, 1994, Use of gastroduodenal manometry to differentiate mechanical and functional intestinal obstruction, Am J Gastroenterol, 89, 339
- O’Brien, 1995, The rumination syndrome, Gastroenterology, 108, 1024, 10.1016/0016-5085(95)90199-X · DOI
- Hyman, 1993, Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction, Am J Gastroenterol, 88, 832
- Verne, 1995, Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction, Dig Dis Sci, 40, 1892, 10.1007/BF02208652 · DOI
- Soffer, 1996, Clinical value of duodenojejunal manometry. Its usefulness in diagnosis and management of patients with gastrointestinal symptoms, Dig Dis Sci, 41, 859, 10.1007/BF02091523 · DOI
- Benini, 1999, Simultaneous measurement of gastric emptying of a solid meal by ultrasound and by scintigraphy, Am J Gastroenterol, 94, 2861, 10.1111/j.1572-0241.1999.01429.x · DOI · Paper page
- Kuiken, 1999, Development of a test to measure gastric accommodation in humans, Am J Physiol, 277, G1217
- Kim, 2001, Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia, Am J Gastroenterol, 96, 3099, 10.1111/j.1572-0241.2001.05264.x · DOI
- Koch, 2000, Reproducibility of gastric myoelectrical activity and the water load test in patients with dysmotility-like dyspepsia symptoms and in control subjects, J Clin Gastroenterol, 31, 125, 10.1097/00004836-200009000-00007 · DOI
- Tack, 2003, Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia, Gut, 52, 1271, 10.1136/gut.52.9.1271 · DOI
- Chial, 2002, A nutrient drink test to assess maximum tolerated volume and postprandial symptoms, Neurogastroenterol Motil, 14, 249, 10.1046/j.1365-2982.2002.00326.x · DOI
- Kong, 1998, Natural history of diabetic gastroparesis, Diabetes Care, 22, 503, 10.2337/diacare.22.3.503 · DOI
- Nowak, 1995, Highly variable gastric emptying in patients with insulin dependent diabetes mellitus, Gut, 37, 23, 10.1136/gut.37.1.23 · DOI
- Schwartz, 1996, Rapid gastric emptying of a solid pancake meal in type II diabetic patients, Diabetes Care, 19, 468, 10.2337/diacare.19.5.468 · DOI
- Frank, 1995, Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus, Gastroenterology, 109, 755, 10.1016/0016-5085(95)90382-8 · DOI
- Horowitz, 1986, Gastric and oesophageal emptying in insulin-dependent diabetes mellitus, J Gastroenterol Hepatol, 1, 97, 10.1111/j.1440-1746.1986.tb00104.x · DOI
- Rayner, 2001, Relationships of upper gastrointestinal motor and sensory function with glycemic control, Diabetes Care, 24, 371, 10.2337/diacare.24.2.371 · DOI
- Ishii, 1995, Influence on glycemic control of improved diabetic gastroparesis by long-term cisapride therapy, Nippon Shokakibyo Gakkai Zasshi, 92, 1724
- Stacher, 1999, Cisapride versus placebo for 8 weeks on glycemic control and gastric emptyng in insulin-dependent diabetes, J Clin Endocrinol Metab, 84, 2357, 10.1210/jc.84.7.2357 · DOI
- Pan, 1995, Effect of oral erythromycin on patients with diabetic gastroparesis, Zhonghua Yi Xue Za Zhi (Taipei), 55, 447
- Melga, 1997, Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis, Diabetes Care, 20, 55, 10.2337/diacare.20.1.55 · DOI
- Ueno, 2000, Erythromycin improves glycaemic control in patients with type II diabetes mellitus, Diabetologia, 43, 411, 10.1007/s001250051323 · DOI
- Braden, 2002, Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control, Aliment Pharmacol Ther, 16, 1341, 10.1046/j.1365-2036.2002.01257.x · DOI
- Lehmann, 2003, Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. A pilot study with cisapride as a model drug, Exp Clin Endocrinol Diabetes, 111, 255, 10.1055/s-2003-41283 · DOI
- Yoshida, 1988, There are no morphologic abnormalities of the gastric wall or abdominal vagus in patients with diabetic gastroparesis, Gastroenterology, 94, 907, 10.1016/0016-5085(88)90546-X · DOI
- Duchen, 1980, Pathology of autonomic neuropathy in diabetes mellitus, Ann Intern Med, 92, 301, 10.7326/0003-4819-92-2-301 · DOI
- Takahashi, 1997, Impaired expression of nitric oxide synthase in gastric myenteric plexus of spontaneously diabetic rats, Gastroenterology, 113, 1535, 10.1053/gast.1997.v113.pm9352855 · DOI
- Ordog, 2000, Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis, Diabetes, 49, 1731, 10.2337/diabetes.49.10.1731 · DOI
- He, 2001, Loss of interstitial cells of Cajal and inhibitory innervation in insulin-dependent diabetes, Gastroenterology, 121, 427, 10.1053/gast.2001.26264 · DOI
- Ejskjaer, 1999, Novel surgical treatment and gastric pathology in diabetic gastroparesis, Diabetic Med, 16, 488, 10.1046/j.1464-5491.1999.00086.x · DOI
- Moscoso, 1986, A form of necrobiosis and atrophy of smooth muscle in diabetic gastric autonomic neuropathy, Pathol Res Pract, 181, 188, 10.1016/S0344-0338(86)80009-7 · DOI
- Fraser, 1990, Hyperglycemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus, Diabetologia, 33, 675, 10.1007/BF00400569 · DOI
- Lam, 1993, Hyperglycemia reduces gastric secretory and plasma pancreatic polypeptide responses to modified sham feeding in humans, Digestion, 54, 48, 10.1159/000201011 · DOI
- Mizuno, 1984, Glucose responding neurons in the nucleus tractus solitarius of the rat, Brain Res, 307, 109, 10.1016/0006-8993(84)90466-9 · DOI
- Hasler, 1995, Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins, Gastroenterology, 108, 727, 10.1016/0016-5085(95)90445-X · DOI
- Jones, 1997, Blood glucose concentrations influences postprandial fullness in IDDM, Diabetes Care, 29, 1141, 10.2337/diacare.20.7.1141 · DOI
- Eagon, 1992, Postgastrectomy syndromes, Surg Clin North Am, 72, 445, 10.1016/S0039-6109(16)45689-6 · DOI
- Mathias, 1985, Nausea, vomiting, and abdominal pain after Roux-en-Y anastomosis, Gastroenterology, 88, 101, 10.1016/S0016-5085(85)80140-2 · DOI
- Vassilakis, 1993, The effect of floppy Nissen fundoplication on esophageal and gastric motility in gastroesophageal reflux, Surg Gynecol Obstet, 177, 608
- Bais, 2001, Impact of delayed gastric emptying on the outcome of antireflux surgery, Ann Surg, 234, 139, 10.1097/00000658-200108000-00002 · DOI
- Haque, 2001, Is there a shift in symptomatology in patients after laparoscopic Nissen fundoplication? (abstr), Am J Gastroenterol, 96, S66, 10.1016/S0002-9270(01)02944-6 · DOI
- Stanghellini, 1983, Gastric manometric abnormalities in patients with dyspeptic symptoms after fundoplication, Gut, 24, 790, 10.1136/gut.24.9.790 · DOI
- Hunter, 1996, Gastroparesis, Am J Gastroenterol, 91, 2617
- Trus, 1997, Complications of laparoscopic paraesophageal hernia repair, J Gastrointest Surg, 1, 221, 10.1016/S1091-255X(97)80113-8 · DOI
- DeVault, 2001, Vagal nerve dysfunction before and after antireflux surgery (abstr), Am J Gastroenterol, 96, S10, 10.1016/S0002-9270(01)02754-X · DOI
- Lundell, 1994, Delayed gastric emptying and its relationship to symptoms of “gas bloat” after antireflux surgery, Eur J Surg, 160, 161
- Mun, 2001, Current status of medical and surgical therapy for obesity, Gastroenterology, 120, 669, 10.1053/gast.2001.22430 · DOI
- Horowitz, 1982, Measurement of gastric emptying after gastric bypass surgery using radionuclides, Br J Surg, 69, 655, 10.1002/bjs.1800691108 · DOI
- Balsiger, 2000, Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity, J Gastrointest Surg, 4, 598, 10.1016/S1091-255X(00)80108-0 · DOI
- Mistiaen, 2000, Gastric emptying rate measurement after vertical banded gastroplasty, Obes Surg, 10, 245, 10.1381/096089200321643377 · DOI
- Berkowitz, 1995, Gastroparesis after lung transplant—potential role in postoperative respiratory complications, Chest, 108, 1602, 10.1378/chest.108.6.1602 · DOI
- Au, 1993, Upper gastrointestinal dysmotility in heart-lung transplant recipients, Ann Thorac Surg, 55, 94, 10.1016/0003-4975(93)90480-6 · DOI
- Sodhi, 2002, Delayed gastric emptying after combined heart and lung transplantation, J Clin Gastroenterol, 34, 34, 10.1097/00004836-200201000-00007 · DOI
- Zarate, 2003, Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration, Gut, 52, 966, 10.1136/gut.52.7.966 · DOI
- Bityutskiy, 1997, Viral gastroparesis, Am J Gastroenterol, 92, 1501
- Oh, 1990, Gastroparesis after a presumed viral illness, Mayo Clin Proc, 65, 636, 10.1016/S0025-6196(12)65125-8 · DOI
- McCallum, 1981, Gastric emptying in patients with gastroesophageal reflux, Gastroenterology, 80, 285, 10.1016/0016-5085(81)90716-2 · DOI
- Keshavarzian, 1991, Gastric emptying in patients with severe reflux esophagitis, Am J Gastroenterol, 86, 738
- Stacher, 2000, Gastric emptying, Gut, 47, 661, 10.1136/gut.47.5.661 · DOI
- Barnert, 2001, Gastroesophageal reflux disease, Gastroenterology, 120, A460, 10.1016/S0016-5085(08)82281-0 · DOI
- Vanderwinden, 1992, Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis, N Engl J Med, 327, 511, 10.1056/NEJM199208203270802 · DOI
- Vanderwinden, 1996, Study of the interstitial cells of Cajal in infantile hypertrophic pyloric stenosis, Gastroenterology, 111, 279, 10.1053/gast.1996.v111.pm8690192 · DOI
- Vanderwinden, 1996, The pathology of infantile hypertrophic pyloric stenosis after healing, J Pediatr Surg, 31, 1530, 10.1016/S0022-3468(96)90171-2 · DOI
- Sun, 2000, Long-term effects of pyloromyotomy on pyloric motility and gastric emptying in humans, Am J Gastroenterol, 95, 92, 10.1111/j.1572-0241.2000.01705.x · DOI
- Honein, 1999, Infantile hypertrophic stenosis after pertussis prophylaxis with erythromycin, Lancet, 354, 2101, 10.1016/S0140-6736(99)10073-4 · DOI
- SanFilippo, 1976, Infantile hypertrophic pyloric stenosis related to ingestion of erythromycin estolate, J Pediatr Surg, 11, 177, 10.1016/0022-3468(76)90283-9 · DOI
- 1999, Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin—Knoxville, Tennessee, 1999, MMWR, 48, 1117
- van Roggen, 1998, Adult hypertrophic pyloric stenosis, J Clin Pathol, 51, 479, 10.1136/jcp.51.6.479 · DOI
- Danikas, 2000, Laparoscopic pyloroplasty in idiopathic hypertrophic pyloric stenosis in an adult, JSLS, 4, 173
- Bonapace, 2000, Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms, Am J Gastroenterol, 95, 2838, 10.1111/j.1572-0241.2000.03195.x · DOI
- Caballero-Plasencia, 1999, Altered gastric emptying in patients with irritable bowel syndrome, Eur J Nucl Med, 26, 404, 10.1007/s002590050404 · DOI
- Tjeerdsma, 1993, Voluntary suppression of defecation delays gastric emptying, Dig Dis Sci, 38, 832, 10.1007/BF01295908 · DOI
- Casey, 1993, Lethal nature of ischemic gastropathy, Am J Surg, 165, 646, 10.1016/S0002-9610(05)80453-2 · DOI
- Liberski, 1990, Ischemic gastroparesis, Gastroenterology, 99, 252, 10.1016/0016-5085(90)91255-5 · DOI
- Sikora, 1995, Functional gastric impairment in carcinoma of the pancreas, Br J Surg, 82, 1112, 10.1002/bjs.1800820835 · DOI
- Lee, 2001, Paraneoplastic gastrointestinal motor dysfunction, Am J Gastroenterol, 96, 373, 10.1111/j.1572-0241.2001.03454.x · DOI
- Schuffler, 1983, Intestinal pseudo-obstruction as the presenting manifestation of small-cell carcinoma of the lung, Ann Intern Med, 98, 129, 10.7326/0003-4819-98-2-129 · DOI
- Layer, 1986, Gastroparesis after radiation—successful treatment with carbachol, Dig Dis Sci, 31, 1377, 10.1007/BF01299817 · DOI
- Brand, 1998, Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation, Lancet, 352, 1985, 10.1016/S0140-6736(05)61330-X · DOI
- Eagle, 2001, Gastroparesis following bone marrow transplantation, Bone Marrow Transplant, 28, 59, 10.1038/sj.bmt.1703084 · DOI
- Iftikhar, 1998, Gastroparesis after celiac plexus block, Am J Gastroenterol, 93, 2223, 10.1111/j.1572-0241.1998.00619.x · DOI
- Chowdhury, 2003, Prevalence of gastroparesis in patients with small duct chronic pancreatitis, Pancreas, 26, 235, 10.1097/00006676-200304000-00005 · DOI
- Lu, 2001, Impaired gastric myoelectrical activity in patients with chronic pancreatitis, Dig Dis Sci, 46, 692, 10.1023/A:1005684328217 · DOI
- Collins, 1997, Gastric emptying time is faster in cystic fibrosis, J Pediatr Gastroenterol Nutr, 25, 492, 10.1097/00005176-199711000-00002 · DOI
- Van Vlem, 2000, Delayed gastric emptying in dyspeptic chronic hemodialysis patients, Am J Kidney Dis, 36, 962, 10.1053/ajkd.2000.19094 · DOI
- De Schoenmakere, 2001, Relationship between gastric emptying and clinical and biochemical factors in chronic haemodialysis patients, Nephrol Dial Transplant, 16, 1850, 10.1093/ndt/16.9.1850 · DOI
- Kebede, 1987, Transient gastroparesis associated with cutaneous herpes zoster, Dig Dis Sci, 32, 318, 10.1007/BF01297060 · DOI
- Meeroff, 1980, Abnormal gastric motor function in viral gastroenteritis, Ann Intern Med, 92, 370, 10.7326/0003-4819-92-3-370 · DOI
- Nowak, 1999, Evolution of acute cytomegalovirus gastritis to chronic gastrointestinal dysmotility in a nonimmunocompromised adult, Gastroenterology, 116, 953, 10.1016/S0016-5085(99)70079-X · DOI
- Van Thiel, 1992, Cytomegalovirus infection and gastric emptying, Transplantation, 54, 70, 10.1097/00007890-199207000-00012 · DOI
- Corley, 1999, Evaluation of upper gastrointestinal tract symptoms in patients infected with HIV, Am J Gastroenterol, 94, 2890, 10.1111/j.1572-0241.1999.01433.x · DOI
- Neild, 2000, Delayed gastric emptying in human immunodeficiency virus infection, Dig Dis Sci, 45, 1491, 10.1023/A:1005587922517 · DOI
- Konturek, 1997, Disturbed motor activity in patients with human immunodeficiency virus infection, Scand J Gastroenterol, 32, 221, 10.3109/00365529709000198 · DOI
- Mearin, 1995, Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia?, Gut, 37, 47, 10.1136/gut.37.1.47 · DOI
- Tucci, 1992, Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia, Gastroenterology, 103, 768, 10.1016/0016-5085(92)90004-I · DOI
- Parkman, 1998, Effect of gastric acid suppressants on human gastric motility, Gut, 42, 243, 10.1136/gut.42.2.243 · DOI
- Ueki, 1993, Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats, J Pharmacol Exp Ther, 264, 152
- Masclee, 1996, Effects of parenteral nutrients on gastrointestinal motility and secretion, Scand J Gastroenterol, 31, 50, 10.3109/00365529609094731 · DOI
- Casaubon, 1989, Intravenous fat emulsion (Intralipid) delays gastric emptying, but does not cause gastroesophageal reflux in healthy volunteers, J Parenter Enteral Nutr, 13, 246, 10.1177/0148607189013003246 · DOI
- Wasdholtz, 1990, Gastrointestinal symptoms in anorexia nervosa—a prospective study, Gastroenterology, 98, 1415, 10.1016/0016-5085(90)91070-M · DOI
- McCallum, 1985, Definition of a gastric emptying abnormality in patients with anorexia nervosa, Dig Dis Sci, 30, 713, 10.1007/BF01320484 · DOI
- Rigaud, 1988, Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program, Dig Dis Sci, 33, 919, 10.1007/BF01535985 · DOI
- Szmukler, 1990, A serial study of gastric emptying in anorexia and bulimia, Aust N Z J Med, 20, 220, 10.1111/j.1445-5994.1990.tb01023.x · DOI
- Mehler, 2003, Bulimia nervosa, N Engl J Med, 349, 875, 10.1056/NEJMcp022813 · DOI
- Chami, 1995, Gastrointestinal symptoms in bulimia nervosa, Am J Gastroenterol, 90, 88
- Kiss, 1990, Oesophageal and gastric motor activity in patients with bulimia nervosa, Gut, 31, 259, 10.1136/gut.31.3.259 · DOI
- Hutson, 1990, Gastric emptying in patients with bulimia nervosa and anorexia nervosa, Am J Gastroenterol, 85, 41
- Thumshirn, 1998, Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome, Am J Physiol, 275, G314
- Malcolm, 1997, Rumination syndrome, Mayo Clin Proc, 72, 646, 10.4065/72.7.646 · DOI
- Pasricha, 1996, Cyclic vomiting, Am J Gastroenterol, 91, 2228
- Abell, 1988, Idiopathic cyclic nausea and vomiting—a disorder of gastrointestinal motility?, Mayo Clin Proc, 63, 1169, 10.1016/S0025-6196(12)65401-9 · DOI
- Boles, 1999, Mitochondrial disease and cyclic vomiting syndrome, Dig Dis Sci, 44, 103S
- Moore, 1981, Gastric emptying of varying meal weight and composition in man, Dig Dis Sci, 26, 16, 10.1007/BF01307971 · DOI
- Bujanda, 2000, The effects of alcohol consumption upon the gastrointestinal tract, Am J Gastroenterol, 95, 3374, 10.1111/j.1572-0241.2000.03347.x · DOI
- Miller, 1989, Smoking delays gastric emptying of solids, Gut, 30, 50, 10.1136/gut.30.1.50 · DOI
- Petiakis, 1999, Hyperglycemia attenuates erythromycin-induced acceleration of solid phase gastric emptying in idiopathic and diabetic gastroparesis, Scand J Gastroenterol, 34, 396, 10.1080/003655299750026416 · DOI
- Muth, 1995, Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness, Aviat Space Environ Med, 66, 1041
- Talley, 2003, Diabetic gastropathy and prokinetics, Am J Gastroenterol, 98, 264, 10.1111/j.1572-0241.2003.07268.x · DOI · Paper page
- Veldhuyzen van Zanten, 1996, Drug treatment of functional dyspepsia, Am J Gastroenterol, 91, 660
- Dobrilla, 1989, Drug treatment of functional dyspepsia—a meta-analysis of randomized controlled clinical trials, J Clin Gastroenterol, 11, 169, 10.1097/00004836-198904000-00011 · DOI
- Finney, 1998, Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia, J Clin Gastroenterol, 26, 312, 10.1097/00004836-199806000-00022 · DOI
- Veldhuyzen van Zanen, 2001, Efficacy of cisapride and domperidone in functional (non ulcer) dyspepsia, Am J Gastroenterol, 96, 689, 10.1016/S0002-9270(00)02314-5 · DOI
- Soo, 2000, A systematic review of pharmacological therapies in non-ulcer dyspepsia (abstr), Gastroenterology, 118, A440, 10.1016/S0016-5085(00)83871-8 · DOI
- Longstreth, 1977, Metoclopramide stimulation of gastric motility and emptying in diabetic gastroparesis, Ann Intern Med, 86, 195, 10.7326/0003-4819-86-2-195 · DOI
- Clarke, 1989, The 5-HT4 receptor, TIPS, 10, 385
- Brownlee, 1974, Metoclopramide for gastroparesis diabeticorum, N Engl J Med, 291, 1257, 10.1056/NEJM197412052912321 · DOI
- Longstreth, 1977, Metoclopramide stimulation of gastric motility and emptying in diabetic gastroparesis, Ann Intern Med, 186, 195, 10.7326/0003-4819-86-2-195 · DOI
- Snape, 1982, Metoclopramide to treat gastroparesis due to diabetes mellitus, Ann Intern Med, 96, 444, 10.7326/0003-4819-96-4-444 · DOI
- McCallum, 1983, A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis, Diabetes Care, 6, 463, 10.2337/diacare.6.5.463 · DOI
- Loo, 1984, Gastric emptying in patients with diabetes mellitus, Gastroenterology, 86, 485, 10.1016/S0016-5085(84)80019-0 · DOI
- Ricci, 1985, Effect of metoclopramide in diabetic gastroparesis, J Clin Gastroenterol, 7, 25, 10.1097/00004836-198502000-00003 · DOI
- Erbas, 1993, Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis, Diabetes Care, 16, 1511, 10.2337/diacare.16.11.1511 · DOI
- Patterson, 1999, A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis, Am J Gastroenterol, 94, 1230
- Lata, 2003, Chronic metoclopramide therapy for diabetic gastroparesis, Ann Pharmacother, 37, 122, 10.1345/aph.1C118 · DOI
- Schade, 1985, Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis, Dig Dis Sci, 30, 10, 10.1007/BF01318364 · DOI
- Trapnell, 1986, Metoclopramide suppositories in the treatment of diabetic gastroparesis, Arch Intern Med, 146, 2278, 10.1001/archinte.146.11.2278 · DOI
- Ganzini, 1993, The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders, Arch Intern Med, 153, 1469, 10.1001/archinte.153.12.1469 · DOI
- Miller, 1989, Metoclopramide-induced movement disorders. Clinical findings with a review of the literature, Arch Intern Med, 149, 2486, 10.1001/archinte.149.11.2486 · DOI
- Peeters, 1993, Erythromycin and other macrolides as prokinetic agents, Gastroenterology, 105, 1886, 10.1016/0016-5085(93)91089-Z · DOI
- Feighner, 1999, Receptor for motilin identified in the human gastrointestinal system, Science, 284, 2184, 10.1126/science.284.5423.2184 · DOI
- Parkman, 1995, Gastrokinetic effects of erythromycin, Am J Physiol, 269, G418
- Janssens, 1990, Improvement of gastric emptying in diabetic gastroparesis by erythromycin, N Engl J Med, 322, 1028, 10.1056/NEJM199004123221502 · DOI
- Dull, 1990, Successful treatment of gastroparesis with erythromycin in a patient with progressive systemic sclerosis, Am J Med, 89, 528, 10.1016/0002-9343(90)90387-S · DOI
- Mozwecz, 1990, Erythromycin stearate as prokinetic agent in postvagotomy gastroparesis, Dig Dis Sci, 35, 902, 10.1007/BF01536806 · DOI
- Klutman, 1992, Erythromycin therapy for gastroparesis, South Med J, 85, 524, 10.1097/00007611-199205000-00013 · DOI
- Erbas, 1993, Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis, Diabetes Care, 16, 1511, 10.2337/diacare.16.11.1511 · DOI
- Richards, 1993, The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin, Am J Gastroenterol, 88, 203
- Ramirez, 1994, Erythromycin enhances gastric emptying in patients with gastroparesis after vagotomy and antrectomy, Dig Dis Sci, 39, 2295, 10.1007/BF02087641 · DOI
- Samson, 1997, Effects of oral erythromycin on fasting and postprandial antroduodenal motility in patients with type 1 diabetes, measured with an ambulatory manometric technique, Diabetes Care, 20, 129, 10.2337/diacare.20.2.129 · DOI
- Talley, 2001, Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus, Gut, 49, 395, 10.1136/gut.49.3.395 · DOI
- Camilleri, 1993, The current role of erythromycin in the clinical management of gastric emptying disorders, Am J Gastroenterol, 88, 169
- Maganti, 2003, Oral erythromycin and symptomatic relief of gastroparesis, Am J Gastroenterol, 98, 259
- Ehrenpreis, 1998, Which form of erythromycin should be used to treat gastroparesis? A pharmacologic analysis, Aliment Pharmacol Ther, 12, 373, 10.1046/j.1365-2036.1998.00302.x · DOI
200 of 277 shown
Cited by
Sorted by citations
Items 201–300 of 667
Guidelines for the Treatment of Functional Dyspepsia
Jee, S. R., Jung, H., Min, B., Choi, K. D., Rhee, P., Kang, Y. W., Lee, S. I., & The Korean Society of Neurogastroenterology and Motility (2011) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2011.57.2.67 · Cited by 32
“위장관 운동촉진제의 용량을 증가시킬 수 있으며 두 종류의 운동촉진제를 병합하여 사용하는 것도 효과가 있었다.(61,62) 증 상 조절이 잘 되지 않는 경우 metoclopramide나 domperidone의 용량을 증가시킬 수 있으며 위장관 운동촉진제의 조 합도 가능하다.”
Pathophysiology and management of gastroparesis
Khoo, J. J. C., Rayner, C. K., Jones, K. L., & Horowitz, M. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.10 · Cited by 40
Gastroparesis on the rise: incidence vs awareness?
Nusrat, S., & Bielefeldt, K. (2013) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.02002.x · Cited by 33
Junqueira, D. R., Bennett, D., Huh, S. Y., Fahrbach, K. R., Neupane, B., & Betts, M. B. (2023) · Drugs in R&D · doi:10.1007/s40268-023-00413-x · Cited by 31
Heckert, J., Thomas, R. M., & Parkman, H. (2017) · Neurogastroenterology and Motility · doi:10.1111/nmo.13068 · Cited by 33
Self-citationHejazi, R. A., Zhang, D., & McCallum, R. W. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31819b93e5 · Cited by 41
The difficult patient with gastroparesis
Tack, J. F. (2007) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2007.01.002 · Cited by 31
Elfvin, A., Andersson, S., Abrahamsson, H., Edebo, A., Simrén, M., & Lönroth, H. (2007) · Neurogastroenterology and Motility · doi:10.1111/j.1365-2982.2006.00858.x · Cited by 33
Pathophysiology of idiopathic gastroparesis and implications for therapy
Bekkelund, M., Sangnes, D. A., Hatlebakk, J. G., & Aabakken, L. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2018.1558280 · Cited by 34
“gastroparesis due to surgery or medication [1].”
BackgroundGastroparesis in Non-Diabetics: Associated Conditions and Possible Risk Factors
Nassar, Y., & Richter, S. J. (2018) · Gastroenterology Research · doi:10.14740/gr1060w · Cited by 35
Endoscopic treatment of gastroparesis
McCarty, T. R., & Rustagi, T. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i22.6842 · Cited by 34
Variation of symptoms during the menstrual cycle in female patients with gastroparesis
Verrengia, M. A., Sachdeva, P., Gaughan, J., Fisher, R. S., & Parkman, H. P. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01681.x · Cited by 33
Self-citationGallas, S., Sinno, M. H., Boukhettala, N., Coëffier, M., Dourmap, N., Gourcerol, G., Ducrotte, P. R., Déchelotte, P., Leroi, A., & Fetissov, S. O. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07474.x · Cited by 28
“Gastric distention participates in the regulation of food intake and, hence, delayed gastric emptying in patients with gastroparesis may contribute to development of early satiety and poor appetite (Parkman et al., 2004).”
BackgroundInfluentialGastric Neuromuscular Function and Neuromuscular Disorders
Koch, K. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00048-2 · Cited by 28
Continuous Glucose Monitoring in Gastroparesis
Ramzan, Z., Duffy, F., Gomez, J., Fisher, R. S., & Parkman, H. P. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1810-z · Cited by 31
“The most common categories of gastroparesis are diabetes mellitus, sequelae of gastric surgery, and idiopathic [1, 2].”
BackgroundSelf-citationAcupuncture for Pain in Chronic Pancreatitis
Juel, J., Liguori, S., Liguori, A., Poulsen, J. L., Valeriani, M., Graversen, C., Olesen, S. S., & Drewes, A. M. (2017) · Pancreas · doi:10.1097/mpa.0000000000000749 · Cited by 37
“C hronic pancreatitis (CP) is characterized by progressive inflammation of the pancreatic gland and irreversible replacement of the pancreatic parenchyma with fibrosis.(1) Chronic pancreatitis is often associated with pain, whereas exocrine or”
BackgroundTreatment of Gastroparesis: An Update
Gumaste, V. V., & Baum, J. (2008) · Digestion · doi:10.1159/000185690 · Cited by 26
“In addition to accelerating gastric motility, metaclopramide has an independent antiemetic effect. Metaclopramide can be administered intravenously, subcutaneously or through the oral route. A liquid preparation is also available.Although there are several studies [”
BackgroundMandarino, F. V., Sinagra, E., Barchi, A., Verga, M. C., Brinch, D., Raimondo, D., & Danese, S. (2023) · Microorganisms · doi:10.3390/microorganisms11051122 · Cited by 29
Gastroparesis in the 2020s: New Treatments, New Paradigms
Sharma, A., Coles, M. J., & Parkman, H. P. (2020) · Current Gastroenterology Reports · doi:10.1007/s11894-020-00761-7 · Cited by 34
Self-citationEffect of Chronic Domperidone Use on QT Interval
Field, J. S., Wasilewski, M. A., Bhuta, R. V., Malik, Z. A., Cooper, J. M., Parkman, H. P., & Schey, R. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001183 · Cited by 32
Self-citationContrast-Enhanced Magnetic Resonance Imaging of Gastric Emptying and Motility in Rats
Lu, K., Cao, J., Oleson, S., Powley, T. L., & Liu, Z. (2017) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2737559 · Cited by 30
“Impairment of such responses may cause gastroparesis [2], [3], obesity [4], and gastroesophageal reflux diseases [5].”
BackgroundGolden, W. E., & Hopkins, R. (2005) · doi:10.1016/s1097-8690(05)71411-6 · Cited by 29
Factors that contribute to the impairment of quality of life in gastroparesis
Parkman, H. P., Wilson, L., Yates, K. P., Koch, K. L., Abell, T. L., McCallum, R. W., Sarosiek, I., Kuo, B., Malik, Z. A., Schey, R., et al. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14087 · Cited by 37
“Several areas impacted on reduced quality of life: (1) Symptoms of nausea, vomiting, and abdominal pain, as well as IBS; (2) Etiology and acute onset and progressively worsening symptoms; (3) Comorbidities and psychological factors such as anxiety and depression; (4) Patient related factors such as smoking.”
Self-citationIchkhanian, Y., Vosoughi, K., Meybodi, M. A., Jacques, J., Sethi, A., Patel, A. R., Aadam, A., Triggs, J. R., Bapaye, A., Dorwat, S., et al. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-07570-z · Cited by 28
Gastric electrical stimulation for treatment of clinically severe gastroparesis
Jayanthi, N., Dexter, S., & Sarela, A. (2013) · Journal of Minimal Access Surgery · doi:10.4103/0972-9941.118833 · Cited by 28
“Gastroparesis is chronic, delayed emptying of the stomach in the absence of any mechanical obstruction.[1] In clinically severe manifestation, gastroparesis can produce continuous nausea and frequent vomiting, resulting in malnutrition, dehydration, and increased risk of thrombosis.”
BackgroundCholecystectomy and Clinical Presentations of Gastroparesis
Parkman, H. P., Yates, K. P., Hasler, W. L., Nguyen, L. A. B., Pasricha, P. J., Snape, W. J., Farrugia, G., Koch, K. L., Calles, J., Abell, T. L., et al. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2596-y · Cited by 30
“Gastroparesis is associated with a variety of symptoms including early satiety, postprandial fullness, nausea, vomiting, and abdominal pain [1, 2].”
BackgroundSelf-citationVanormelingen, C., Tack, J., & Andrews, C. (2013) · British Medical Bulletin · doi:10.1093/bmb/ldt003 · Cited by 28
Parkman, H., Yates, K. P., Sarosiek, I., Bulat, R. S., Abell, T., Koch, K., Kuo, B., Grover, M., Farrugia, G., Silver, P., et al. (2023) · Alimentary Pharmacology and Therapeutics · doi:10.1111/apt.17479 · Cited by 27
“Subgroups displayed are (1) aetiology: Diabetic vs Idiopathic, (2) bloating: severe/very severe vs none to moderate, (3) Water Load Satiety Test volume consumed: Low vs Normal, (4) Narcotic use 3+ times/week or less: No use vs used.”
Self-citationBhidayasiri, R., Phuenpathom, W., Tan, A. H., Leta, V., Phumphid, S., Chaudhuri, К. R., & Pal, P. K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.979826 · Cited by 28
“The initial assessment of gastroparesis should be done by taking a careful clinical history of prevalent GI symptoms, noting those that occur most commonly, with the aim of ruling out any other conditions with similar or overlapping symptoms (Parkman et al., 2004).”
BackgroundGastrointestinal Dysfunction in Parkinson’s Disease
Safarpour, D., Sharzehi, K., & Pfeiffer, R. F. (2022) · Drugs · doi:10.1007/s40265-021-01664-1 · Cited by 36
“Because levodopa is absorbed in the proximal small intestine, delayed emptying of gastric contents can also result in altered levodopa responsiveness, with delayed and erratic onset of action (delayed ON) or even complete failure of response to a levodopa dose (dose failure) [77, 123, 124].”
BackgroundTakahashi, R., Ohashi, M., Hiki, N., Makuuchi, R., Ida, S., Kumagai, K., Sano, T., & Nunobe, S. (2020) · Gastric Cancer · doi:10.1007/s10120-019-01037-4 · Cited by 30
Botulinum Toxin as a Treatment for Refractory Gastroparesis: a Literature Review
Thomas, A., Ribeiro, B. D. S., Malespin, M., & de Melo, S. W. (2018) · Current treatment options in gastroenterology · doi:10.1007/s11938-018-0187-x · Cited by 27
Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI‐daily diary
Heckert, J., & Parkman, H. (2018) · Neurogastroenterology and Motility · doi:10.1111/nmo.13246 · Cited by 27
Self-citationOthman, M. O., Davis, B. R., Saroseik, I., Torabi, A., & McCallum, R. W. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.06.056 · Cited by 25
Ghrelin, appetite and gastric electrical stimulation
Gallas, S., & Fetissov, S. O. (2011) · Peptides · doi:10.1016/j.peptides.2011.05.027 · Cited by 9
Diabetic gastroparesis: Therapeutic options
Alam, U., Asghar, O., & Malik, R. A. (2010) · Diabetes Therapy · doi:10.1007/s13300-010-0010-8 · Cited by 26
Chen, Y. J., Tang, W., Ionescu‐Ittu, R., Ayyagari, R., Wu, E. Q., Huh, S. Y., & Parkman, H. P. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14366 · Cited by 29
Self-citationKuo, B., Barnes, C. N., Nguyen, D. D., Shaywitz, D. A., Grimaldi, M., Renzulli, C., Canafax, D. M., & Parkman, H. P. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16344 · Cited by 33
Self-citationState-of-the-art pharmacotherapy for diabetic neuropathy
Azmi, S., Alam, U., Burgess, J., & Malik, R. A. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1812578 · Cited by 30
“Gastroparesis is defined as the delayed removal of stomach contents in the absence of a physical obstruction [170].”
BackgroundNovel Soy Germ Pasta Enriched in Isoflavones Ameliorates Gastroparesis in Type 2 Diabetes
Setchell, K. D. R., Nardi, E., Battezzati, P. M., Asciutti, S., Castellani, D., Perriello, G., & Clerici, C. (2013) · Diabetes Care · doi:10.2337/dc12-1615 · Cited by 26
Nutritional therapy for the management of diabetic gastroparesis: clinical review
Sadiya, A. (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s31962 · Cited by 34
Ben‐Youssef, R., Baron, P., Franco, E., Walter, M., Lewis, T., & Ojogho, O. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01153.x · Cited by 26
Stapleton, J. R., & Wo, J. M. (2009) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2008.12.008 · Cited by 23
Parkman, H. P., Sharkey, E. P., Nguyen, L. A. B., Yates, K. P., Abell, T. L., Hasler, W. L., Snape, W. J., Clarke, J. O., Schey, R., Koch, K. L., et al. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05963-2 · Cited by 34
Self-citationCannabinoid Use in Patients With Gastroparesis and Related Disorders: Prevalence and Benefit
Jehangir, A., & Parkman, H. P. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000181 · Cited by 30
Self-citationRevicki, D., Speck, R., Lavoie, S., Puelles, J., Kuo, B., Camilleri, M., Almansa, C., & Parkman, H. (2019) · Neurogastroenterology and Motility · doi:10.1111/nmo.13553 · Cited by 25
Self-citationParkinson’s Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects
Ramprasad, C., Douglas, J. Y., & Moshiree, B. (2018) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-018-0201-3 · Cited by 27
Do HbA1C Levels Correlate With Delayed Gastric Emptying in Diabetic Patients?
Reddy, S. C., Ramsubeik, K., Vega, K. J., Federico, J. R., & Palacio, C. (2010) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2010.16.4.414 · Cited by 27
An 8-year review of barium studies in the diagnosis of gastroparesis
Levin, A. A., Levine, M. S., Rubesin, S. E., & Laufer, I. (2007) · Clinical Radiology · doi:10.1016/j.crad.2007.10.007 · Cited by 30
Childhood gastroparesis is a unique entity in need of further investigation
Febo‐Rodriguez, L., Chumpitazi, B. P., & Shulman, R. J. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13699 · Cited by 30
Nutritional Considerations in the Patient with Gastroparesis
Parrish, C. R. (2014) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2014.11.007 · Cited by 27
Hejazi, R. A., & McCallum, R. W. (2009) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2008.12.010 · Cited by 25
2023 update on the clinical management of gastroparesis
Halabi, M. E., & Parkman, H. P. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2196404 · Cited by 24
Self-citationBody weight in patients with idiopathic gastroparesis
Parkman, H. P., Natta, M. L. V., Yamada, G., Grover, M., McCallum, R. W., Sarosiek, I., Farrugia, G., Koch, K. L., Abell, T. L., Kuo, B., et al. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13974 · Cited by 26
Self-citationHedjoudje, A., Huet, E., Leroi, A., Desprez, C., Melchior, C., & Gourcerol, G. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13949 · Cited by 21
Li, B., Luo, X.-F., Liu, S.-W., Zhao, N., Li, H.-N., Zhang, W., Chen, Y.-Y., Bao, A., Wang, J.-G., & Wang, Q.-S. (2020) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2020/3912931 · Cited by 23
Alolaiwi, L. A., Alharbi, T., & Tourkmani, A. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209500 · Cited by 26
Malik, R., Srivastava, A., Gambhir, S., Yachha, S. K., Siddegowda, M., Ponnusamy, M., & Poddar, U. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13145 · Cited by 24
Li, G.-M., Huang, C., Zhang, X.-Z., Xie, H., Cheng, H.-Y., Tang, Y., & Li, Z.-G. (2015) · Acupuncture in Medicine · doi:10.1136/acupmed-2014-010670 · Cited by 23
Rapid improvement in post-infectious gastroparesis symptoms with mirtazapine
Kundu, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i21.6671 · Cited by 24
Wu, Y.-S., Lu, H., Huang, X., Liu, D., Meng, X., Guo, X., Kim, Y., & Xu, W. (2013) · Peptides · doi:10.1016/j.peptides.2012.12.024 · Cited by 26
Varadarajan, P., Dunford, L. M., Thomas, J., Brown, K., Paplham, P., Syta, M., Schiff, M. D., Padmanabhan, S., Battiwalla, M., Smiley, S., et al. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.02.002 · Cited by 23
Gastroparesis secondary to a demyelinating disease: a case series
Reddymasu, S. C., Bonino, J. A., & McCallum, R. W. (2007) · BMC Gastroenterology · doi:10.1186/1471-230x-7-3 · Cited by 24
“Symptoms usually include nausea, vomiting, post prandial fullness, and abdominal pain [1].”
BackgroundYan, J., Tan, Y.-Y., Zhou, B., Zhang, S.-L., Wang, X.-H., & Liu, D.-L. (2020) · Revista Espanola de Enfermedades Digestivas · doi:10.17235/reed.2020.6559/2019 · Cited by 22
“Besides, parasympathetic dysfunction and vagus nerve injury are also considered as the underlying factors in gastroparesis pathogeneses (5).”
BackgroundBotulinum Toxin A Improves Symptoms of Gastroparesis
Reichenbach, Z. W., Stanek, S., Patel, S., Ward, S. J., Malik, Z. A., Parkman, H. P., & Schey, R. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05885-z · Cited by 27
Self-citationRaven, L. M., Brown, C., & Greenfield, J. R. (2024) · Medical Journal of Australia · doi:10.5694/mja2.52170 · Cited by 21
“25 We propose that if patients are treated with additional drugs that slow gastric emptying, further consideration of this risk should be accounted for when deciding fasting time and airway support.”
BackgroundHollis, E., Murray, H. B., & Parkman, H. P. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14725 · Cited by 19
Self-citationA New Paradigm Shift in Gastroparesis Management
Mekaroonkamol, P., Tiankanon, K., & Rerknimitr, R. (2022) · Gut and Liver · doi:10.5009/gnl210309 · Cited by 20
Jehangir, A., & Parkman, H. P. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5125-1 · Cited by 24
Self-citationGibbons, S. J., Grover, M., Choi, K. M., Wadhwa, A., Zubair, A. S., Wilson, L., Wu, Y., Abell, T. L., Hasler, W. L., Koch, K. L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187772 · Cited by 25
Self-citationTseng, P., Wu, Y., Lee, Y., Cheng, M., Tzen, K., Wang, H., Lin, J., Hsieh, S., Yang, W., & Wu, M. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12640 · Cited by 19
Serotonergic signalling in the stomach and duodenum of patients with gastroparesis
van Lelyveld, N., ter Linde, J., Schipper, M., & Samsom, M. (2008) · Neurogastroenterology and Motility · doi:10.1111/j.1365-2982.2007.01068.x · Cited by 21
“For inclusion, two symptoms had to be scored three or higher on a scale of 0 – 5: mild ( 1-2 ); tolerated without interference with usual”
Song, G.-Q., Hou, X., Yang, B., Sun, Y., Qian, W., & Chen, J. D. Z. (2007) · Surgery · doi:10.1016/j.surg.2007.07.001 · Cited by 23
Diabetic gastroparesis: clinical features, diagnosis and management
Ahmed, M. S., Forde, H. E., & Smith, D. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-022-03191-8 · Cited by 24
Imaging Review of Gastrointestinal Motility Disorders.
Nehra, A., Sheedy, S., Johnson, C. D., Flicek, K. T., Venkatesh, S. K., Heiken, J., Wells, M. L., Ehman, E., Barlow, J., Fletcher, J., et al. (2022) · Radiographics · doi:10.1148/rg.220052 · Cited by 20
Risk Factors and Outcomes for Gastroparesis After Lung Transplantation
Blackett, J. W., Benvenuto, L. J., Leiva‐Juárez, M. M., D’Ovidio, F., Arcasoy, S. M., & Jodorkovsky, D. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07249-y · Cited by 22
Opioid-Induced Foregut Dysfunction.
Patel, D., Callaway, J., & Vaezi, M. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000354 · Cited by 20
Omer, E. M., Kedar, A., Nagarajarao, H., Nikitina, Y., Vedanarayanan, V., Subramony, C., Lahr, C., & Abell, T. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001025 · Cited by 20
Diagnosing and managing diabetic somatic and autonomic neuropathy
Azmi, S., Ferdousi, M., Kalteniece, A., Almuhannadi, H., Al‐Mohamedi, A., Hadid, N. H., Mahmoud, S., Bhat, H., Gad, H., Khan, A., et al. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819826890 · Cited by 22
The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis
Revicki, D., Lavoie, S., Speck, R., Puelles, J., Kuo, B., Camilleri, M., Almansa, C., & Parkman, H. (2018) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-018-0081-2 · Cited by 20
Self-citationLi, P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i5.1518 · Cited by 21
Gastric Peroral Endoscopic Myotomy
Chung, H., & Khashab, M. (2018) · Clinical Endoscopy · doi:10.5946/ce.2018.001 · Cited by 19
A 64-channel wireless implantable system-on-chip for gastric electrical-wave recording
Ibrahim, A., Kiani, M., & Farajidavar, A. (2016) · Italian National Conference on Sensors · doi:10.1109/icsens.2016.7808742 · Cited by 19
“5 million people in the US and up to ~10% of patients with diabetes, and is increasing due to the diabetes epidemic with hospitalizations rising 150% in the last decade with major associated costs [2], [3].”
BackgroundAssessment of the cardiovascular and gastrointestinal autonomic complications of diabetes
Brock, C., Brock, B., Pedersen, A. G., Drewes, A. M., Jessen, N., & Farmer, A. D. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i16.321 · Cited by 24
Ghrelin and gastroparesis as early predictors of clinical outcomes in acute pancreatitis
Wu, L. M., Premkumar, R., Phillips, A. R. J., Windsor, J. A., & Petrov, M. S. (2015) · Pancreatology · doi:10.1016/j.pan.2015.12.002 · Cited by 17
Treatment of gastrointestinal autonomic neuropathy
Törnblom, H. (2015) · Diabetologia · doi:10.1007/s00125-015-3828-9 · Cited by 21
“The recommendations for the medications available for the treatment of gastroparesis were based on the findings of old trials that do not meet the modern, more rigorous standards of evidence [7].”
BackgroundPrevalence of symptoms suggestive of gastroparesis in a cohort of patients with diabetes mellitus.
Dickman, R., Kislov, J., Boaz, M., Ron, Y., Beniashvili, Z., Raz, I., Baigel, I., Niv, Y., & Wainstein, J. (2013) · Journal of diabetes and its complications · doi:10.1016/j.jdiacomp.2013.02.004 · Cited by 19
“The standard technique for measuring gastric emptying rate (GER) is by gastric scintigraphy (Parkman et al., 2004).”
Gastric Electrical Stimulation in Gastroparesis: Where Do We Stand?
Mönnikes, H., & van der Voort, I. R. (2006) · Digestive Diseases · doi:10.1159/000092879 · Cited by 17
“Other causes of gastroparesis include: collagen vascular diseases as scleroderma and amyloidosis; post-surgical after partial gastric resection, vagotomy, post-bariatric surgery, or Nissen fundoplication; eating disorders as anorexia; gastrointestinal disorders as gastroesophageal reflux disease, achalasia, functional…”
BackgroundMedical and surgical management of gastroparesis: a systematic review
Mora, M. C. F., Matute, C. M., Alemán, R., Castillo, M., Giambartolomei, G., Schneider, A., Szomstein, S., Menzo, E. L., & Rosenthal, R. J. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.10.027 · Cited by 19
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia.
Arnold, F., Lopardo, G., Wiemken, T., Kelley, R., Peyrani, P., Mattingly, W. A., Feldman, C., Gnoni, M., Maurici, R., & Ramirez, J. A. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.05.020 · Cited by 18
“First, the immunomodulatory properties of macrolides that enhanced gastro-motility in patients without CAP show that they have at least one clinical impact, and second, it is unknown how those properties might be relevant in CAP [27].”
BackgroundBenefits of Acupuncture for Diabetic Gastroparesis: A Comparative Preliminary Study
Miller, N. D., Schiff, E., Ben‐Arye, E., Singer, J., Perets, T. T., Flaut, S., Sahar, N., Niv, Y., & Dickman, R. M. (2013) · Acupuncture in Medicine · doi:10.1136/acupmed-2013-010465 · Cited by 20
Prokinetics in Diabetic Gastroparesis
Hejazi, R. A., McCallum, R. W., & Sarosiek, I. (2012) · Current Gastroenterology Reports · doi:10.1007/s11894-012-0275-3 · Cited by 16
Yalçın, H., Okuyucu, E. E., Uçar, E., Duman, T., & Yılmazer, S. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2012.02741.x · Cited by 20
Laparoscopic Pylorus-preserving Gastrectomy Versus Distal Gastrectomy for Early Gastric Cancer
Lee, H.-J., Kim, Y.-W., Park, D., Han, S.-U., Ryu, K., Kim, H.-H., Woo, J., Park, J.-H., Suh, Y., Kwon, O.-K., et al. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006503 · Cited by 17
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions
Caturano, A., Cavallo, M., Nilo, D., Vaudo, G., Russo, V., Galiero, R., Rinaldi, L., Marfella, R., Monda, M., Luca, G., et al. (2024) · Gastrointestinal Disorders · doi:10.3390/gidisord6010016 · Cited by 17
“In the evaluation of suspected gastroparesis, it is imperative to exclude mechanical obstructions through diagnostic procedures such as upper endoscopy, computed tomography, or magnetic resonance enterography [78].”
MethodImaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment
Mandarino, F. V., Testoni, S. G. G., Barchi, A., Azzolini, F., Sinagra, E., Pepe, G., Chiti, A., & Danese, S. (2023) · Life · doi:10.3390/life13081743 · Cited by 18
“Major GP symptoms include nausea, vomiting, abdominal pain, early satiety, postprandial fullness, stomach distension, and bloating [38].”
BackgroundAbell, T., Kuo, B., Esfandyari, T., Pfeifer, N., Grimaldi, M., Renzulli, C., Tacchi, R., Zhou, K., Barnes, C., Nguyen, D. D., et al. (2023) · Neurogastroenterology and Motility · doi:10.1111/nmo.14523 · Cited by 17
Shanker, A., Bashashati, M., & Rezaie, A. R. (2021) · Current Gastroenterology Reports · doi:10.1007/s11894-020-00803-0 · Cited by 22
Diabetes and Metabolic Disorders and the Peripheral Nervous System
Gibbons, C. H. (2020) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000906 · Cited by 21
Sensory neuromodulators in functional nausea and vomiting: predictors of response
Patel, A. C., Sayuk, G. S., Kushnir, V. M., & Gyawali, C. P. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2012-131284 · Cited by 18
Metadata
- Authors
- Parkman, H. P., Hasler, W. L., & Fisher, R. S.
- Affiliations
- Temple University (US)
- University of Michigan (US)
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 127
- Issue
- 5
- Pages
- 1592-1622
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1968058596
- Cited by
- 738
- References
- 295
- Citations by year
- 2026: 19 · 2025: 31 · 2024: 28 · 2023: 28 · 2022: 29 · 2021: 40 · 2020: 52 · 2019: 54 · 2018: 44 · 2017: 26 · 2016: 28 · 2015: 35 · 2014: 31 · 2013: 40 · 2012: 34
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Keywords
- gastroparesis, diagnosis, treatment, clinical guidelines, delayed gastric emptying
- MeSH terms
- Breath Tests, Diagnosis, Differential, Gastric Emptying, Gastrointestinal Motility, Humans, Gastroparesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review